- Our Doctors
- Dr Yuvnik Trada

Dr Yuvnik Trada
BPharm, MBBS (Hons), FRANZCR, Radiation Oncologist
Languages spoken
English, Hindi, Gujarati
Overview
Centres
Clinical interests
Clinical interests in Genitourinary, Prostate, Head and Neck, Skin and Gastrointestinal Cancers.
Dr Yuvnik Trada is a radiation oncologist with expertise in caring for people with genitourinary, head and neck, complex skin, gastrointestinal, and hepatobiliary cancers. He is passionate about providing personalised, evidence-based treatment using the latest advances in radiotherapy.
Yuvnik completed a Bachelor of Pharmacy prior to graduating from a Bachelor of Medicine with Honours in 2011. He completed his radiation oncology training in Brisbane and Newcastle, followed by a Fellowship in Head and Neck Cancer at Liverpool Hospital. He has been recognised with awards including the Varian Research Prize and the CE Eddy Prize for the most outstanding performance in the radiation oncology examinations.
Yuvnik is Director of Research in Radiation Oncology at Calvary Mater Newcastle and Conjoint Senior Lecturer at the University of Newcastle. He is widely published, leads several national clinical trials, and is completing a PhD at the University of Sydney focusing on personalising radiotherapy using functional imaging. He also plays an active role in education and teaching, helping to mentor the next generation of cancer specialists.
Yuvnik believes in supporting patients and their families through every step of treatment, ensuring care is compassionate, clear, and tailored to each individual’s needs.
Professional memberships
- Australian and New Zealand urogenital and prostate cancer trials group (AGITG)
- Trans-Tasman radiation oncology group (TROG)
- Australian gastro-intestinal cancer group trails group (AGITG)
- Australian and New Zealand head and neck cancer society (ANZHNSC)
- The international society of magnetic resonance in medicine (ISMRM)

Publications
- Trada, Y., Keall, P., Jameson, M., Moses, D., Lin, P., Chlap, P., ... & Lee, M. T. (2023). Changes in serial multiparametric MRI and FDG-PET/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer. European Radiology, 33(12), 8788-8799.
- Trada, Y., Kneebone, A., Paneghel, A., Pearse, M., Sidhom, M., Tang, C., ... & Martin, J. (2015). Optimizing radiation therapy quality assurance in clinical trials: a TROG 08.03 RAVES substudy. International Journal of Radiation Oncology* Biology* Physics, 93(5), 1045-1051.
- Trada, Y., Lee, M. T., Jameson, M. G., Chlap, P., Keall, P., Moses, D., Lin, P., & Fowler, A. (2023, September). Mid-treatment 18F-FDG PET imaging changes in parotid gland correlates to radiation-induced xerostomia. Radiotherapy & Oncology, 186, 109745. https://doi.org/10.1016/j.radonc.2023.109745
- Trada, Y., Lee, M. T., Jameson, M. G., Chlap, P., Keall, P., Moses, D., ... & Fowler, A. (2025). Mid-treatment changes in intra-tumoural metabolic heterogeneity correlate to outcomes in oropharyngeal squamous cell carcinoma patients. EJNMMI research, 15(1), 31.
- Trada, Y., Plank, A., & Martin, J. (2013). Defining a dose–response relationship for prostate external beam radiotherapy. Journal of medical imaging and radiation oncology, 57(2), 237-246.
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.